Showing results (1211-1220 of 1,265) with videos related to
Sort By:
Pageof 127
ESMO Open|July 19, 2018
TRIPLETE: a randomised phase III study of modified FOLFOXIRI plus panitumumab versus mFOLFOX6 plus panitumumab as initial therapy for patients with unresectable <i>RAS</i> and <i>BRAF</i> wild-type metastatic colorectal cancerBeatrice Borelli, Roberto Moretto, Sara Lonardi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2018
Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III TrialsCesare Gridelli, Alessandro Morabito, Luigi Cavanna, et al.Lung Cancer (Amsterdam, Netherlands)|June 16, 2019
Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trialsAlessandro Morabito, Maria Carmela Piccirillo, Paolo Maione, et al.The EMBO Journal|February 10, 2023
Immunity against Moraxella catarrhalis requires guanylate-binding proteins and caspase-11-NLRP3 inflammasomesDaniel Enosi Tuipulotu, Shouya Feng, Abhimanu Pandey, et al.Annals of Hepatology|July 19, 2023
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?Raffaele Brustia, Mohamed Bouattour, Manon Allaire, et al.Journal of Chemotherapy (Florence, Italy)|February 14, 2022
Risk-adjusted analysis of survival variability among hospitals treating biliary malignancyMargherita Rimini, Andrea Casadei-Gardini, Giovanni Brandi, et al.International Journal of Cancer|June 20, 2022
Platinum sensitivity in patients with IDH1/2 mutated vs wild-type intrahepatic cholangiocarcinoma: A propensity score-based studyMonica Niger, Federico Nichetti, Andrea Casadei-Gardini, et al.JHEP Reports : Innovation in Hepatology|November 9, 2020
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence areaGiuliana Amaddeo, Raffaele Brustia, Manon Allaire, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2025
Re-treatment with panitumumab followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with RAS and BRAF wild-type circulating tumor DNA: the PARERE study by GONOP Ciracì, M M Germani, F Pietrantonio, et al.Science Advances|December 6, 2023
DECTIN-1: A modifier protein in CTLA-4 haploinsufficiencyCynthia Turnbull, Josiah Bones, Maurice Stanley, et al.Pageof 127